SCHEMBL8124752

SCHEMBL8124752

c1ccc2cc(CN3CCN(c4nccc5ccccc45)CC3)ccc2c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.57
HRH4 Q9H3N8 1/20 0.57
HTR2C P28335 1/20 0.53
PKM P14618 1/20 0.52
MC4R P32245 1/20 0.52
MC5R P33032 1/20 0.52
SORD Q00796 1/20 0.51
CHKA P35790 1/20 0.50
HDAC3 O15379 1/20 0.50
HDAC4 P56524 1/20 0.50
HDAC1 Q13547 1/20 0.50
HDAC7 Q8WUI4 1/20 0.50
HDAC2 Q92769 1/20 0.50
HDAC10 Q969S8 1/20 0.50
HDAC11 Q96DB2 1/20 0.50
HDAC8 Q9BY41 1/20 0.50
HDAC6 Q9UBN7 1/20 0.50
HDAC9 Q9UKV0 1/20 0.50
HDAC5 Q9UQL6 1/20 0.50
HTR1A P08908 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL8110649 0.99 KMT2A (0.56) KMT2AHRH4HTR2CPKMMC4R
SCHEMBL6232120 0.87 HRH4 (0.62) HRH4HTR2CSORDHTR1AACHE
SCHEMBL8118469 0.86 HRH4 (0.53) KMT2AHRH4HTR2CSORDHTR1A
SCHEMBL8134359 0.86 MEN1 (0.58) KMT2AHRH4HTR2CSORDHTR1A
SCHEMBL8486348 0.85 HRH4 (0.60) KMT2AHRH4HTR2CSORDHTR1A
SCHEMBL3684916 0.85 KDM4E (0.59) KMT2AHRH4HTR2CSORDHTR1A
SCHEMBL8130723 0.84 SIGMAR1 (0.58) KMT2AHRH4HTR2CSORDACHE
SCHEMBL8130421 0.84 HRH4 (0.56) KMT2AHRH4HTR2CSORDHTR1A
SCHEMBL11815804 0.81 KMT2A (0.56) KMT2AHTR2CPKMMC4RMC5R
Oxalic Acid SCHEMBL8133977 0.81 HRH4 (0.47) KMT2AHRH4HTR2CSORDHTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0970054-A1 1-(ISOQUINOLIN-1-YL)-4-(1-PHENYLMETHYL)PIPERAZINES; DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS NEUROGEN CORPORATION (US) 2000-01-12 EP claimed
US-6008352-A USEFUL IN TREATING PSYCHOTIC DISORDERS SUCH AS SCHIZOPHRENIA AND OTHER CENTRAL NERVOUS SYSTEM DISEASES NEUROGEN CORPORATION (US) 1999-12-28 US claimed
WO-1998039301-A1 1-(ISOQUINOLIN-1-YL)-4-(1-PHENYLMETHYL)PIPERAZINES; DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS NEUROGEN CORPORATION (US) 1998-09-11 WO claimed